Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000935836-25-000008
Filing Date
2025-01-02
Accepted
2025-01-02 18:17:02
Documents
1
Period of Report
2024-12-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10043
  Complete submission text file 0000935836-25-000008.txt   12173
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Issuer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address
NODELMAN OLEG (Reporting) CIK: 0001454385 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37985 | Film No.: 25503274

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Reporting) CIK: 0001587114 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37985 | Film No.: 25503275